[1]
Sansone, S., Amir, Y. and Lebwohl, M. 2020. Safe use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients with a History of Lymphoproliferative Disease. SKIN The Journal of Cutaneous Medicine. 4, 3 (May 2020), 256-259. DOI:https://doi.org/10.25251/skin.4.3.7.